As of 2025-07-12, the Intrinsic Value of XBiotech Inc (XBIT) is -6.46 USD. This XBIT valuation is based on the model Peter Lynch Fair Value. With the current market price of 2.83 USD, the upside of XBiotech Inc is -328.35%.
Based on its market price of 2.83 USD and our intrinsic valuation, XBiotech Inc (XBIT) is overvalued by 328.35%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -6.46 - -6.46 | -6.46 | -328.35% |
| P/E | (13.65) - (24.40) | (17.97) | -734.8% |
| DDM - Stable | (11.06) - (32.06) | (21.56) | -861.7% |
| DDM - Multi | (9.75) - (22.27) | (13.59) | -580.3% |
| Market Cap (mil) | 86.29 |
| Beta | 1.19 |
| Outstanding shares (mil) | 30.49 |
| Enterprise Value (mil) | -69.61 |
| Market risk premium | 4.60% |
| Cost of Equity | 9.91% |
| Cost of Debt | 5.00% |
| WACC | 9.36% |